目的研究小于扰RNA(siRNA)的新型阳离子脂质体的制备,考察此脂质体-小干扰RNA复合物对LNCap细胞中靶mRNA的沉默效应。方法采用逆向蒸发法制备新型阳离子脂质体,并加入鱼精蛋白和小牛胸腺DNA以增加其对小干扰RNA的压缩,评价其理化性质;以LNCap细胞为模型,以lipofectamine2000作为阳性对照,用RT—PCR方法研究脂质体-小干扰RNA复合物对前列腺癌细胞中靶基因Plk-1的沉默效应。结果制备的脂质体(2,3-二油氧基丙基)三甲基氯化铵胆固醇的最佳比例为3:1,粒径为(117±4.3)nm,Zeta电位为(47±3.6)mV;新型阳离子脂质体小干扰RNA复合物的入胞效率显著提高,荧光显微镜显示LNCap细胞内小干扰RNA含量明显升高。结论本实验所制备的阳离子脂质体具有较高转染效率,脂质体-小干扰RNA复合物的沉默效果显著。此新型阳离子脂质体有望成为小干扰RNA等基因治疗药物的高效传递系统。
OBJECTIVE To investigate the preparation of novel cationic liposomes encapsulating siRNA, and evaluate their si-lence efficiency on target mRNA in LNCap cells. METHODS Reverse evaporation technique was used to prepare the cationic lipo-somes. Protamine and calf thymus DNA were added to increase the encapsulation efficiency. The physicochemical property of the lipo-somes was evaluated. Human prostate cancer cells, LNCap, were used as the cell model. The silence efficiency on target gene in LN-Cap cells was evaluated with lipofectamine 2000 as the positive control. RESULTS The optimum liposomes were obtained when the ratio of DOTAP and cholesterol was 3:1 and the ratio of liposomes and siRNA was 300: 1. The size distribution and Zeta potential of the liposomes were ( 117 ± 4. 3 ) nm and (43 ± 3.6) mV, respectively. The liposomes significantly improved siRNA accumulation in cells. CONCLUSION The novel cationic liposome showed high transfection efficiency and distinct silence efficiency for target gene, which are expected to become a highly effective drug delivery system for anti-cancer drugs.